OCBC (SGX:O39)’s 1H20 PAT disappointed Street/MKE on larger than expected provisioning charges. The group has had a number of negative surprises on its O&M exposure in the past and it manifested in the current quarter too. Additionally, around 10% of their loan book is under moratoriums, which may begin to see pressure as these expire in 2H20. NPL risks spilling over to 2021-22 cannot be discounted.
Separately, operational normalisation may be muted for the group’s ASEAN businesses given the various stages of lockdowns, while North Asia may be a bright spot.
Dividend caps may keep yields depressed and uncertain in the near term. Maintain HOLD.
Credit Charge Risks on the Upside
While 6.8% of OCBC’s Singapore loans are on moratorium, it is 48% for Malaysian exposures. Malaysian moratoriums are set to expire in 3Q20. In Singapore’s scheme customers have to opt-in for relief, Malaysian moratoriums are given by default. As a result, cash flows of individual credits are harder to assess at this stage, according to Management. This may create elevated risks of NPLs going forward, in our view.
Additionally, OCBC took SPs for a specific shipping exposure in 2Q and continue to write down O&M credits. 1H20 credit charges reached 106bps. Its guidance on total credit charges are 100-130bps for 2020- 2021E. However, management claims actuals may come towards the higher end of the range. We have raised allowances for 2020-2022E by 17-36%.
Cautious Growth
OCBC's 1H20 PPOP fell 5% y-o-y despite a strong contribution from insurance. Management struck a cautious tone on growth with a focus on cost management in the near term. 25% of loans are in North Asia, which may be a bright spot given earlier lifting of lockdowns there. But this may not be enough. 2Q20 loan growth in Greater China was 6% y-o-y whereas Singapore was flat and ASEAN fell 3% for the Group.
Lowering Target Price to SGD9.06. Maintain HOLD
We have adjusted down dividends expectations in-line with MAS guidelines and have kept absolute payout flat in 2021E, given expectations of a slow regional recovery.
Our post 1H20 adjustments have lowered 2020-2022E PAT by 1-10%. We have reduced our multi-stage DDM (COE 9.7%, 3% terminal) Target Price to SGD9.06 (from SGD9.46).
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....